Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Neuroimmune Dysfunction in Alcohol Use Disorder

NCT04210713 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT04210713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04210713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Neuroimmune Dysfunction in Alcohol Use Disorder
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 1
Overall status
Completed
Start date
February 3, 2020
Completion date
September 20, 2023
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol drinking, alcohol-related disorders, alcoholism, anti-bacterial agents, anti-infective agents, chemically-induced disorders, cognition disorder, cognitive dysfunction, disease, drinking behavior, inflammation, mental disorder, minocycline, neurocognitive disorders, pathologic processes, substance-related disorders